OS-053 Fecal microbiota transplantation combined with atezolizumab plus bevacizumab in hepatocellular carcinoma refractory to atezolizumab plus bevacizumab: final results of the open label, single-arm, FAB-HCC pilot study

Journal of Hepatology 2026

View at publisher
Authors: Katharina Pomej, Adrian Frick, Bernhard Scheiner, Maximilian Baumgartner, Klaus Schmetterer, Lorenz Balcar, Larissa Pajancic, Abelina Kreuter, Petra Pjevac, Joana Paula Pereira Barbosa Roque da Silva, Bela Hausmann, Thomas Köcher
+14 more Carlos S. Reyna-Blanco, Katharina Lampichler, Nataliya Rohr-Udilova, A Chakrabarty, Anton Klotz, Annika Lampl, Kerstin Zinober, Katharina Regnat, Michael Trauner, David Berry, Thomas Vogl, Dietmar Tamandl, Christoph Gasché, Matthias Pinter
DOI: 10.1016/s0168-8278(26)00363-6
Cited by: 1

Fields of Study & Subjects

Clostridium difficile and Clostridium perfringens research Gut microbiota and health Hepatitis B Virus Studies

Publication details

Journal / source
Journal of Hepatology
Publisher
Elsevier BV
Volume
84
Pages
S37–S38
Publication date
1 May 2026
Language
EN